Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
about
Safety and efficacy of the off-label use of milrinone in pediatric patients with heart diseasesEvaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.Prevention for pediatric low cardiac output syndrome: results from the European survey EuLoCOS-Paed.
P2860
Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
@en
Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
@nl
type
label
Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
@en
Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
@nl
prefLabel
Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
@en
Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
@nl
P2860
P1476
Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe
@en
P2093
Stephanie Läer
Winnie Vogt
P2860
P2888
P304
P356
10.1007/S00134-011-2266-5
P577
2011-06-07T00:00:00Z